Profile of neurohumoral agents on mesenteric and intestinal blood flow in health and disease.
The mesenteric and intestinal blood flow is organized and regulated to support normal intestinal function, and the regulation of blood flow is, in part, determined by intestinal function itself. In the process of the development and adaptation of the intestinal mucosa for the support of the digestive processes and host defense mechanisms, and the muscle layers for propulsion of foodstuffs, a specialized microvascular architecture has evolved in each tissue layer. Compromised mesenteric and intestinal blood flow, which can be common in the elderly, may lead to devastating clinical consequences. This problem, which can be caused by vasospasm at the microvascular level, can cause intestinal ischaemia to any of the layers of the intestinal wall, and can initiate pathological events which promote significant clinical consequences such as diarrhea, abdominal angina and intestinal infarction. The objective of this review is to provide the reader with some general concepts of the mechanisms by which neurohumoral vasoactive substances influence mesenteric and intestinal arterial blood flow in health and disease with focus on transmural transport processes (absorption and secretion). The complex regulatory mechanisms of extrinsic (sympathetic-parasympathetic and endocrine) and intrinsic (enteric nervous system and humoral endocrine) components are presented. More extensive reviews of platelet function, atherosclerosis, hypertension, diabetes mellitus, the carcinoid syndrome, 5-hydroxytryptamine and nitric oxide regulation of vascular tone are presented in this context. The possible options of pharmacological intervention (e.g. vasodilator agonists and vasoconstrictor antagonists) used for the treatment of abnormal mesenteric and intestinal vascular states are also discussed.
Hansen
M B
MB
Microvascular Research Institute, Department of Surgery, State University of New York, Health Science Center at Brooklyn, USA.
Dresner
L S
LS
Wait
R B
RB
D000818:Animals; D001783:Blood Flow Velocity / Q000187:drug effects; D004194:Disease; D006262:Health; D006801:Humans; D007422:Intestines / Q000098:blood supply*; D018377:Neurotransmitter Agents / Q000494:pharmacology*; D009569:Nitric Oxide / Q000502:physiology; D012701:Serotonin / Q000502:physiology; D013152:Splanchnic Circulation / Q000187:drug effects*
D018377:Neurotransmitter Agents; D009569:Nitric Oxide; D012701:Serotonin